Nanoviricides (NNVC) Total Non-Current Liabilities (2013 - 2019)

Nanoviricides has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $1.1 million for Q1 2019.

• In Q1 2019, Total Non-Current Liabilities fell 52.68% year-over-year to $1.1 million; the TTM figure through Mar 2019 stood at $1.1 million (down 52.68% YoY), while the FY2018 annual figure was $881948.0, down 56.24% from the prior year.
• Total Non-Current Liabilities came in at $1.1 million for Q1 2019 at Nanoviricides, up from $881948.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $13.2 million in Q1 2015 to a low of $881948.0 in Q2 2018.
• Average Total Non-Current Liabilities over 5 years is $6.0 million, with a median of $5.9 million recorded in 2016.
• Year-over-year, Total Non-Current Liabilities surged 43.0% in 2015 and slumped 79.28% in 2017.
• Over 5 years, Total Non-Current Liabilities stood at $11.0 million in 2015, then plunged by 46.33% to $5.9 million in 2016, then plunged by 73.29% to $1.6 million in 2017, then plunged by 44.05% to $881948.0 in 2018, then climbed by 22.94% to $1.1 million in 2019.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $1.1 million in Q1 2019, $881948.0 in Q2 2018, and $2.3 million in Q1 2018.